- Home
- POWI vs NKTR Comparison
POWI vs NKTR Comparison
Compare POWI & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | POWI | NKTR |
|---|---|---|
| Founded | 1988 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 1997 | 1996 |
Fundamental Metrics
Financial Performance| Metric | POWI | NKTR |
|---|---|---|
| Price | $46.97 | $71.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $61.00 | ★ $129.83 |
| AVG Volume (30 Days) | 870.8K | ★ 1.5M |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.79% | N/A |
| EPS Growth | N/A | ★ 60.00 |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $443,504,000.00 | $307,711,000.00 |
| Revenue This Year | $8.12 | N/A |
| Revenue Next Year | $16.54 | N/A |
| P/E Ratio | $123.96 | ★ N/A |
| Revenue Growth | 5.86 | ★ 86.00 |
| 52 Week Low | $30.86 | $0.43 |
| 52 Week High | $63.04 | $75.67 |
Technical Indicators
Market Signals| Indicator | POWI | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 52.71 | 67.76 |
| Support Level | $44.13 | $52.99 |
| Resistance Level | $49.03 | $75.67 |
| Average True Range (ATR) | 2.08 | 4.81 |
| MACD | -0.10 | -0.39 |
| Stochastic Oscillator | 35.83 | 67.15 |
Price Performance
Historical ComparisonAbout POWI Power Integrations Inc.
Power Integrations Inc designs, develops, and markets analog and mixed-signal integrated circuits (ICs) and other electronic components and circuitry used in high-voltage power conversion. Products are used in power converters that convert electricity from a high-voltage source to the type of power required for a specified downstream use. Products are used in electronic products including mobile phones, computing and networking equipment, appliances, electronic utility meters, battery-powered tools, industrial controls, home automation, or Internet of Things applications such as networked thermostats, power strips, and security devices. Geographically, the company generates maximum revenue from China and Hong Kong.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.